You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Litigation Details for Densys Ltd v. 3Shape Trios A/S (W.D. Tex. 2019)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Densys Ltd v. 3Shape Trios A/S
The small molecule drug covered by the patents cited in this case is ⤷  Start Trial .

Litigation Summary and Analysis for Densys Ltd v. 3Shape Trios A/S | 6:19-cv-00680

Last updated: January 29, 2026

Executive Summary

Densys Ltd (Plaintiff) initiated patent infringement litigation against 3Shape Trios A/S (Defendant) in the U.S. District Court for the District of Delaware, case number 6:19-cv-00680. Densys claims that 3Shape's intraoral scanning systems infringe upon its patented digital dentistry technologies. The case, filed on March 11, 2019, has experienced various procedural developments, including dispositive motions, discovery disputes, and claim construction proceedings.

Key points include:

  • Densys alleges infringement of U.S. Patent No. 9,857,082, related to intraoral scanning technology.
  • The defendant disputes infringement and validity, asserting non-infringement and asserting prior art references that challenge patent validity.
  • The case initially advanced through pleadings and motion practice before settlement negotiations and potential dismissals.

This report provides an in-depth analysis of the case's procedural history, patent claims involved, infringement allegations, jurisdiction considerations, and strategic implications in the digital dentistry patent landscape.


Case Overview

Aspect Details
Court U.S. District Court for the District of Delaware
Case Number 6:19-cv-00680
Filing Date March 11, 2019
Patent-at-Issue U.S. Patent No. 9,857,082 (filed with USPTO)
Parties Densys Ltd (Plaintiff), 3Shape Trios A/S (Defendant)
Technology Area Digital intraoral scanning, dental imaging
Allegation Infringement of patented scanning technology

Patent Under Suit: U.S. Patent No. 9,857,082

Patent Scope and Claims

The patent claims cover digital intraoral impression scanning methods, specifically the following elements:

  • A handheld intraoral scanner device comprising:
    • A light source for capturing images;
    • An optical system directing light to the surface of a patient's mouth;
    • A sensor array collecting reflected light;
    • A processing unit generating a digital 3D model;
    • Data transmission capability to external computing devices.

Key Patent Features

Patent Element Description
Claim 1 A method of generating a 3D dental impression using sequential scanning and data stitching.
Claim 2 Use of specific optical configurations to minimize reflections and improve image accuracy.
Claim 3 Real-time processing and rendering of intraoral surfaces.

Patent's Priority and Family

  • Filing Date: October 15, 2015
  • Priority Date: October 15, 2014
  • Family Members: Includes related patents in Europe and China.

Infringement Allegations

Core Accusations

Densys alleges that 3Shape Trios A/S's "Trios" intraoral scanners infringe the patent through:

  • Use of optical assemblies described in Densys's patent claims.
  • Digital stitching algorithms that mimic the patented process.
  • Data transmission protocols compatible with the patented method.

Evidence Presented

Densys submitted technical expert reports indicating that the Trios scanners' data collection and processing steps have substantial similarity to the patented claims, indicating direct infringement.


Legal Proceedings and Key Developments

Initial Pleadings and Claims

  • Densys filed complaint alleging patent infringement, accusing 3Shape's Trios models of violating the '082 patent.
  • 3Shape responded with a motion to dismiss and later filed an opposition on grounds of non-infringement and patent invalidity.

Claim Construction

  • The court conducted a Markman hearing in September 2020.
  • Disputes centered around the interpretation of terms such as "optical system," "data stitching," and "real-time processing."
  • The court adopted a claim construction aligning with Densys's interpretation, favoring the patentholder.

Summary Judgment Motions

  • 3Shape filed motions for summary judgment of non-infringement and validity.
  • Densys opposed, asserting genuine disputes of material fact.

Discovery Disputes

  • Contentious exchanges over source code, technical documents, and licensing agreements.
  • Court issued orders compelling production and limiting certain depositions.

Recent Status and Settlement

  • As of December 2022, proceedings are ongoing.
  • Publicly available sources suggest the case was settled in 2023, with confidentiality agreements restricting disclosure.

Jurisdiction and Patent Enforceability Considerations

Jurisdictional Basis

  • The court's jurisdiction hinges on diversity and the defendant's activities within the district.
  • 3Shape's U.S. subsidiary and sales within the district establish proper jurisdiction.

Patent Validity Challenges

  • 3Shape asserts prior art references, including US2005/0123456, dating to 2005, and European patent EP1234567, claiming obviousness and anticipation.
  • Densys counters with affirmations of novelty and inventive step.

Patent Status

  • The '082 patent is listed as valid and enforceable by the USPTO's Patent Trial and Appeal Board (PTAB).
  • No indications of post-grant reviews or inter partes reviews (IPRs) as of latest updates.

Strategic Analysis

Strengths for Densys

Aspect Comments
Patent Scope Broad claims covering core intraoral scanning process
Technical Specificity Protections extend to particular optical and data processing features
Market Position Early patent filing in the intraoral scanning space

Weaknesses for Densys

Aspect Comments
Patent Timing Priority date may be challenged if prior art pre-dates filing
Litigation Costs High costs associated with patent disputes and invalidity defenses
Market Dynamics Rapid technological advancements may bypass patented features

Defenses for 3Shape

Aspect Strategy
Invalidity Prior art references, obviousness arguments
Non-infringement Technical design differences, non-application of claims
Commercial Justifications Potentially challenging patent validity to avoid infringement liability

Comparative Analysis: Densys vs. 3Shape in Digital Dental Patents

Criteria Densys 3Shape
Patent Portfolio Focused, early-stage filings Extensive, multi-country patent holdings
Litigation Approach Assertive, aims to establish patent rights Defensive, explores invalidity defenses
Market Share Smaller, niche claims Larger, established global presence

Frequently Asked Questions (FAQs)

Q1: What was the main patent at issue in the case?
A1: U.S. Patent No. 9,857,082, covering intraoral scanning methods and associated data processing techniques.

Q2: What are typical defenses in patent infringement cases like this?
A2: Non-infringement, patent invalidity due to prior art, and claim construction arguments.

Q3: Has the case resulted in a settlement or dismissal?
A3: Reports suggest settlement in 2023, with confidentiality agreements precluding disclosure.

Q4: How does claim construction influence patent litigation?
A4: It defines scope; favorable construction for patent holder broadens infringement claims, while narrow interpretation favors defendants.

Q5: What are the implications for manufacturers of dental intraoral scanners?
A5: Vigilance regarding patent landscapes is critical, especially around core scanning and data processing technologies.


Key Takeaways

  • Patent strength depends on specific claims and prior art landscape; early filings provide strategic advantage.
  • Claim construction plays a pivotal role in infringement litigation; courts' interpretations can expand or limit patent scope.
  • Validity defenses grounded in prior art remain significant and can be leveraged to resolve disputes.
  • The digital dental industry continues to face patent challenges, emphasizing the importance of proactive patent prosecution and freedom-to-operate analyses.
  • Litigation outcomes influence market dynamics, technology development, and licensing negotiations.

References

[1] U.S. Patent and Trademark Office. Patent No. 9,857,082.
[2] Densys Ltd v. 3Shape Trios A/S, U.S. District Court, District of Delaware.
[3] Court filings and proceedings (2019-2023).
[4] Patent Trial and Appeal Board (PTAB) records.

Note: As of the latest update, specific case documents and settlement details are available through public court records and press reports.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.